Supplemental material
Acta Oncologica
Volume 57, 2018 - Issue 3
ORIGINAL ARTICLES: GYNAECOLOGIC MALIGNANCIES
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
Elisabet HjerpeDepartment of Oncology and Pathology, Karolinska University Hospital, Stockholm, Sweden; ;Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden; Correspondence[email protected]
http://orcid.org/0000-0001-9456-5392View further author information
http://orcid.org/0000-0001-9456-5392View further author information, , , , , Erik HolmbergRegional Cancer Center Western Sweden, Sahlgrenska University Hospital, Gothenburg, Sweden; ;Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden; http://orcid.org/0000-0001-5107-4550View further author information
http://orcid.org/0000-0001-5107-4550View further author information, , , , , , & show allReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study.
Source:
Taylor & Francis
Linking provided by
